Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of rituximab versus another antitumor agent (Japan)
jRCT2080222771Phase 3Completed
- Start
- Feb 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3 trial of rituximab in cancer (2 arms). Started Feb 2015; status: completed.
02
Drugs
rituximab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222771.